一个关于自性障碍的更新
Hormos Salimi Dafsari1,2, Diego Martinelli3, Afshin Saffari4
1Department of Pediatrics and Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Journal of inherited metabolic disease
|October 18, 2024
概括
由基因缺陷引起的先天性自性疾病,存在神经和多器官问题. 研究正在推动对这些疾病和潜在治疗方法的理解.
科学领域:
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
- 临床医学 临床医学
背景情况:
- 宏观自对于细胞平衡至关重要,特别是在转移后组织中.
- 自基因的缺陷导致具有共同临床特征的先天性疾病,如神经发育和神经退行性问题.
- 由EPG5基因缺陷引起的Vici综合征是先天性自性障碍的一个关键例子.
研究的目的:
- 审查与细胞内贩运有关的自.
- 描述先天性自性障碍,其临床特征和推的健康监测.
- 讨论最近的分子机制和未来的治疗策略.
主要方法:
- 关于自途径和相关遗传疾病的文献综述.
- 对已识别的自相关疾病的临床和遗传数据的分析.
- 综合当前关于病理生理学和治疗开发的研究.
主要成果:
- 在核心机械之外,识别了众多与自相关的疾病基因.
- 扩大先天性自性障碍的范围,将选择性自性和膀性贩运联系起来.
- 增强对病理生理学的理解,为治疗开发提供基础.
结论:
- 自的先天性疾病代表了显著的临床和分子谱.
- 基础研究的进步对于了解疾病机制和开发疗法至关重要.
- 初级健康监测协议对于管理这些罕见的遗传疾病至关重要.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
The Proteasome
816
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
816
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


